N@N

Laura Chico Maintained (APLS) at Hold with Increased Target to $60 on, Jan 12th, 2024

Laura Chico of Wedbush, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Increased Target from $39 to $60 on, Jan 12th, 2024.

Laura has made no other calls on APLS in the last 4 months.

There are 11 other peers that have a rating on APLS. Out of the 11 peers that are also analyzing APLS, 3 agree with Laura's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $54 on, Thursday, December 14th, 2023
• Graig Suvannavejh of "Mizuho" Initiated at Hold and Held Target at $42 on, Thursday, November 2nd, 2023
• Brian Cheng of "B of A Securities" Maintained at Hold with Increased Target to $46 on, Thursday, October 12th, 2023

These are the ratings of the 8 analyists that currently disagree with Laura

---

• Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
• Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
• Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $75 on, Friday, December 15th, 2023
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $67 on, Friday, December 15th, 2023
• Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $56 on, Thursday, December 14th, 2023
• Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $85 on, Tuesday, December 5th, 2023
• Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $81 on, Friday, October 6th, 2023
• Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $82 on, Tuesday, September 26th, 2023

Contributing Sources

---